Effect of the Inhibition of the Mammalian Target of Rapamycin on Metabolism and Exercise
Status:
Terminated
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This is an exploratory study based on the hypothesis that kidney transplant patients treated
with an immunosuppressive therapy based on an inhibitor of the mammalian target of rapamycin
(m-TOR) may increase resistance to physical exercise, which would result in an improvement in
the quality of life of these patients.